Sanli Pharmaceutical (603439)
SSE · 603439
Market Cap$6.5B
Revenue$1.7B
Employees1887
Listed OnSSE
Ticker603439
CEO / ExecMr. Qianfan Zhang
HeadquartersAnshun
MarketMainland China
Websitewww.gz-sanli.com
Overview
Guizhou Sanli Pharmaceutical Co.,Ltd, together with its subsidiaries, engages in the plantation, research, development, production, and sale of pharmaceutical products in China. The company offers respiratory system, tonic, gynecological, and orthopedic medications, as well as cardiovascular and cerebrovascular drugs, and other medicines. It also provides products in various dosage forms, including sprays, granules, capsules, pills, tablets, medicated wines, and ointments. The company was founde
Data Note
This record combines exchange-directory fields with selected profile enrichment. Treat market data, leadership and financial figures as directional unless verified against company filings, exchange announcements or the issuer's own disclosures.